Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

5.19
-0.1000-1.89%
Volume:26.59K
Turnover:139.57K
Market Cap:16.57M
PE:-0.22
High:5.34
Open:5.20
Low:5.13
Close:5.29
52wk High:67.50
52wk Low:4.11
Shares:3.19M
Float Shares:3.14M
Volume Ratio:0.60
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.3991
EPS(LYR):-36.5197
ROE:-273.88%
ROA:-111.74%
PB:2.98
PE(LYR):-0.14

Loading ...

Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 11, 2024

Major Issues Report

Form 8-K - Current report